This study aims to describe an association between the Pfizer-BioNTech (BNT162b2) vaccine and decreased risk of symptomatic and asymptomatic infections with SARS-CoV-2 in hospital employees.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8220512 | PMC |
http://dx.doi.org/10.1001/jama.2021.6564 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!